Corrigendum: Clinical Protocol for a Longitudinal Cohort Study Employing Systems Biology to Identify Markers of Vaccine Immunogenicity in Newborn Infants in The Gambia and Papua New Guinea

Affiliations

• ¹ Vaccines and Immunity Theme, Medical Research Council Unit the Gambia at London School of Hygiene and Tropical Medicine, Fajara, Gambia.
• ² Precision Vaccines Program, Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
• ³ CIH LMU Center for International Health, Medical Center of the University of Munich (LMU), Munich, Germany.
• ⁴ The Vaccine Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.
• ⁵ Harvard Medical School, Boston, MA, United States.
• ⁶ PROOF Centre of Excellence, Vancouver, BC, Canada.
• ⁷ Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.
• ⁸ Division of Medicine Critical Care, Harvard Medical School, Boston Children's Hospital, Boston, MA, United States.
• ⁹ Department of Cardiology, Boston Children's Hospital, Boston, MA, United States.
• ¹⁰ Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Nedlands, WA, Australia.
• ¹¹ Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea.
• ¹² BC Cancer Agency, Vancouver, BC, Canada.
• ¹³ Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada.
• ¹⁴ Department of Pathology, Boston Children's Hospital, Boston, MA, United States.
• ¹⁵ Department of Microbiology & Immunology, University of British Columbia, Vancouver, BC, Canada.
• ¹⁶ Centre for Heart Lung Innovation, University of British Columbia, Vancouver, BC, Canada.
• ¹⁷ Division of Respiratory Medicine, Department of Medicine, UBC, Vancouver, BC, Canada.
• ¹⁸ Division of Pediatrics, School of Medicine, Perth Children's Hospital, University of Western Australia, Nedlands, WA, Australia.
• ¹⁹ Broad Institute of MIT & Harvard, Cambridge, MA, United States.